Rhelion Life Sciences Corp. (CSE:RHEL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
Aug 10, 2026, 12:18 PM EST

Rhelion Life Sciences Company Description

Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe.

The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes.

Its products also include PEX010, a natural psilocybin drug candidate for depression, PTSD, cancer-related distress and substance use disorders; IBEXX, a botanical ibogaine drug candidate for substance use disorders; and MB2500, a whole-leaf coca extract drug candidate for neuropsychiatric indications.

It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap’s brands through brick-and-mortar SmartShops, as well as through online stores.

The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026.

Rhelion Life Sciences Corp. is based in Toronto, Canada.

Rhelion Life Sciences Corp.
CountryCanada
IndustrySecurity Brokers, Dealers, and Flotation Companies
CEOTodd Shapiro

Contact Details

Address:
1 Adelaide Street East
Toronto, ON M5C 2V9
Canada
Phone647 204 7129
Websiterhelion.com

Stock Details

Ticker SymbolRHEL
ExchangeCanadian Securities Exchange
Fiscal YearApril - March
Reporting CurrencyCAD
SIC Code6211

Key Executives

NamePosition
Todd ShapiroChief Executive Officer
Keith LiChief Financial Officer
Lisa RankenChief Operating Officer